Home / Going-concern warnings / Envoy Medical, Inc.
Filed 2026-05-11 路 Form 10-Q 路 Accession 0001213900-26-054209 nano
Price before filing: $0.6455 (2026-05-08 close, split/dividend-adjusted)
Market cap at flag: $44.4M (2026-05-11) 路 Latest: $69.5M (2026-10-16)
| Window | COCH | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +1.4% | -1.7% | +3.1% | 2026-06-10 |
| 90 days | +9.2% | +5.1% | +4.1% | 2026-08-10 |
| 180 days | pending | pending | until 2026-11-07 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 6 insiders bought $8.2M (6 purchases)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | BRYNELSEN CHARLES Director | Purchase | 1,000,000 | $0.40 | $400K | no | Form 4 |
| 2026-02-12 | Kantor Susan Director | Purchase | 96,150 | $0.40 | $38K | no | Form 4 |
| 2026-02-12 | Lucas Brent T. Chief Executive Officer, Director | Purchase | 62,500 | $0.40 | $25K | no | Form 4 |
| 2026-02-12 | Patel Mona Chetan Director | Purchase | 312,500 | $0.40 | $125K | no | Form 4 |
| 2026-02-12 | Potashnick Robert Interim CFO | Purchase | 212,500 | $0.40 | $85K | no | Form 4 |
| 2026-02-12 | TAYLOR GLEN A 10% owner | Purchase | 18,750,000 | $0.40 | $7.5M | no | Form 4 |
| 2026-05-11: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-02-10 to 2026-06-10. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These matters raise substantial doubt about our ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2026-03-31)
Why this score: quarterly (unaudited) disclosure; also within 90 days: Auditor change
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.